Breaking News, Collaborations & Alliances

Alector, Lonza Partner for Mfg. of Neurodegeneration Therapies

Alector and Lonza Pharma & Biotech extend their partnership to cover future manufacturing needs of two of Alector’s clinical stage product candidates

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Alector and Lonza have formed an agreement to secure manufacturing capacity for two of Alector’s drug candidates currently in phase 1 development for neurodegenerative diseases. The California-based biotech chose Lonza’s Ibex Solutions to ensure drug supply and accelerate market-readiness.   The two companies have been working together since 2016 on the early phases of development for Alector’s lead candidates. Based on the potential product needs of these candidates, Lonza’s GS Xceed Gene Exp...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters